Automation and compliance considerations for life sciences organizations

The coronavirus has changed the way life sciences, medical device and pharmaceutical companies interact with healthcare providers (HCPs). As companies adjust their operations to remote work arrangements, automating processes where professionals engage with HCPs is more important than ever.

Listen to Baker Tilly’s on-demand webinar for a discussion about how life sciences companies are utilizing automation software to streamline the contracting, planning, payment and reconciliation processes of their products and devices with HCPs. Our informative discussion also addresses:

  • How COVID-19 has impacted commercial life sciences organizations
  • How companies are utilizing automation software to create efficiencies in their operations
  • What considerations businesses should take to ensure regulatory compliance
  • What internal controls should be established to mitigate risks

Download the presentation

arrowCreated with Sketch.

Visit the Coronavirus Resource Center

For more information on this topic, or to learn how Baker Tilly’s Value Architects™ can help, contact our team.

Coronavirus (COVID-19) data analysis
Next up

COVID-19 Triage plan part 7: details of DoD’s draft Sec. 3610 process guidance as of May 21, 2020